News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
352,525 Results
Type
Article (33162)
Company Profile (125)
Press Release (319238)
Section
Business (94266)
Career Advice (616)
Deals (14361)
Drug Delivery (54)
Drug Development (50093)
Employer Resources (54)
FDA (7666)
Job Trends (8206)
News (167521)
Policy (16490)
Tag
Academia (2274)
Alliances (28270)
Alzheimer's disease (670)
Antibody-drug conjugate (ADC) (90)
Approvals (7661)
Artificial intelligence (91)
Bankruptcy (118)
Best Places to Work (7108)
Biotechnology (99)
Breast cancer (202)
Cancer (1458)
Career advice (534)
CAR-T (91)
Cell therapy (227)
Clinical research (39125)
Collaboration (331)
Compensation (81)
COVID-19 (1645)
C-suite (67)
Data (886)
Diabetes (70)
Diagnostics (4141)
Earnings (28423)
Events (53477)
Executive appointments (221)
FDA (8072)
Funding (271)
Gene therapy (81)
GLP-1 (233)
Government (3218)
Healthcare (12016)
Infectious disease (1696)
Inflammatory bowel disease (58)
Interviews (89)
IPO (7219)
Job creations (1373)
Job search strategy (482)
Layoffs (184)
Legal (2987)
Liver cancer (70)
Lung cancer (220)
Lymphoma (96)
Manufacturing (103)
Medical device (4673)
Medtech (4673)
Mergers & acquisitions (7242)
Metabolic disorders (156)
Neuroscience (793)
NextGen Class of 2024 (4032)
Non-profit (4008)
Northern California (928)
Obesity (71)
Opinion (106)
People (30437)
Phase I (13725)
Phase II (17122)
Phase III (12159)
Pipeline (306)
Policy (60)
Postmarket research (1477)
Preclinical (6014)
Prostate cancer (69)
Radiopharmaceuticals (232)
Rare diseases (123)
Real estate (2580)
Regulatory (11216)
Research institute (2151)
Resumes & cover letters (73)
Southern California (761)
Startups (1973)
United States (8117)
Vaccines (344)
Date
Today (16)
Last 7 days (37)
Last 30 days (1193)
Last 365 days (19363)
2024 (19363)
2023 (21999)
2022 (29072)
2021 (31171)
2020 (30071)
2019 (27131)
2018 (20137)
2017 (16827)
2016 (16646)
2015 (19280)
2014 (14629)
2013 (12009)
2012 (12546)
2011 (13094)
2010 (11706)
Location
Africa (405)
Arizona (81)
Asia (23181)
Australia (4271)
California (1971)
Canada (757)
China (245)
Colorado (86)
Connecticut (97)
Delaware (60)
Europe (46339)
Florida (286)
Georgia (63)
Illinois (253)
Indiana (113)
Maryland (437)
Massachusetts (1478)
Minnesota (128)
New Jersey (676)
New York (670)
North Carolina (322)
Northern California (928)
Ohio (74)
Pennsylvania (402)
South America (507)
Southern California (761)
Texas (387)
Washington State (261)
352,525 Results for "national cancer institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.
March 7, 2024
·
4 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
Business
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced a strategic collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health.
June 4, 2024
·
5 min read
Press Releases
Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
November 12, 2024
·
5 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Business
ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research
ATCC will continue to support the National Cancer Institute’s (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.
March 19, 2024
·
3 min read
Business
Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC
Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC.
May 21, 2024
·
2 min read
Press Releases
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
October 29, 2024
·
2 min read
Pharm Country
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing
Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced the peer-reviewed publication of positive data from a National Cancer Institute -sponsored, prospective, multicenter clinical validation study assessing the performance of Lucid’s EsoGuard® Esophageal DNA Test on samples collected with its EsoCheck® Esophageal Cell Collection Device.
May 2, 2024
·
8 min read
Press Releases
National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment
November 4, 2024
·
3 min read
1 of 35,253
Next